Digital Insomnia Therapeutics Market Report 2026

The digital insomnia therapeutics market size has grown strongly in recent years. It will grow from $3.48 billion in 2025 to $3.7 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to high prevalence of sleep disorders, limitations of sleep medications, early digital health adoption, increasing mental health awareness, smartphone-based therapy growth.

The digital insomnia therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to clinical validation of digital therapeutics, wearable data integration, demand for drug-free treatments, ai-driven sleep analytics, telehealth expansion. Major trends in the forecast period include rising adoption of digital cbt-i programs, increasing use of sleep tracking applications, growth of non-pharmacological sleep therapies, expansion of app-based insomnia management, integration of wearables for sleep monitoring.

The increasing adoption of digital health is expected to drive the growth of the digital insomnia therapeutics market in the coming years. Digital health encompasses the use of digital technologies, tools, and platforms to improve healthcare delivery, enhance patient outcomes, and enable individuals to manage their health more effectively. Adoption is rising due to the demand for accessible and cost-effective healthcare solutions, the growing burden of chronic diseases, increased awareness of preventive care, and the expansion of telehealth services. Digital insomnia therapeutics support digital health initiatives by offering technology-driven solutions such as mobile applications and wearable devices to monitor, diagnose, and manage sleep disorders, promoting improved health outcomes and integration with broader healthcare ecosystems. For instance, in July 2024, according to the European Commission, a Belgium-based organization, the Digital Decade eHealth Indicator Study reported that average access to electronic health records through online portals across the EU increased to 79%, up from 72% in 2022. Therefore, the rising adoption of digital health is fueling the growth of the digital insomnia therapeutics market.

Major companies operating in the digital insomnia therapeutics market are concentrating on developing advanced solutions such as software-based mobile applications to deliver personalized, accessible, and cost-effective treatment options for insomnia management. Software-based mobile apps are digital applications designed for smartphones and tablets that support insomnia management through features including sleep tracking, relaxation exercises, cognitive behavioral therapy, and personalized sleep guidance. For instance, in August 2024, Big Health Inc., a US-based mental health services company, received U.S. Food and Drug Administration approval for SleepioRx, a digital therapeutic designed to treat chronic insomnia in adults as an adjunct to standard care. SleepioRx delivers evidence-based cognitive and behavioral techniques that address the underlying factors contributing to chronic insomnia and sleep disturbances.

In June 2023, Nox Health Inc., a US-based provider of sleep diagnostics and value-based sleep care management, acquired Somryst for an undisclosed amount. Through this acquisition, Nox Health expanded its digital sleep care portfolio by gaining access to Somryst’s FDA-cleared digital insomnia therapeutic and evidence-based CBT-I technology, strengthening its capabilities in chronic insomnia treatment and broadening its reach across patient populations.

Major companies operating in the digital insomnia therapeutics market are Pear Therapeutics Inc., Calm.com Inc., Headspace Inc., Big Health Inc., Click Therapeutics Inc., Silvercloud Health Limited, OPTT Inc., Bodymatter Inc., SleepCogni Limited, Stellar Sleep, SleepScore Labs, Sliiip, SUSMED Inc., HelloBetter, AIMMED, Sleepstation (Born Digital Health), NOCTEM Health, Somryst, BetterNight, Minddistrict, Sleep Reset, SleepSpace, Black Dog Institute (Sleep Ninja), Insomnia‑Coach, CBT‑i Coach, ZenSleep, DrLullaby, Night Owl Sleep Coach.

North America was the largest region in the digital insomnia therapeutics market in 2025. The regions covered in the digital insomnia therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital insomnia therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs impact the digital insomnia therapeutics market by increasing costs of imported wearables, biofeedback devices, and VR-based therapy tools. North America and Europe are most affected due to dependence on imported hardware, while Asia-Pacific faces higher adoption costs. These tariffs raise device prices. However, they encourage domestic manufacturing and localized digital therapy solutions.

The digital insomnia therapeutics market research report is one of a series of new reports that provides digital insomnia therapeutics market statistics, including digital insomnia therapeutics industry global market size, regional shares, competitors with a digital insomnia therapeutics market share, detailed digital insomnia therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital insomnia therapeutics industry. This digital insomnia therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital insomnia therapeutics are technology-based solutions developed to treat or manage insomnia by improving sleep quality and addressing its underlying causes. These therapies use tools such as mobile applications, wearable devices, and online platforms to deliver evidence-based interventions. A commonly used approach is cognitive behavioral therapy for insomnia (CBT-I), which focuses on modifying negative thoughts and behaviors that disrupt sleep.

The main types of digital insomnia therapeutics include sleep tracking apps, relaxation and meditation apps, cognitive behavioral therapy for insomnia, wearable devices, and other solutions. Sleep tracking apps are designed to monitor and analyze sleep patterns, offering actionable insights and recommendations to enhance sleep quality and identify potential sleep issues. These solutions are distributed through channels such as hospital pharmacies, retail pharmacies, and other outlets, and are used across medical and household applications.

The digital insomnia therapeutics market includes revenues earned by entities by providing services such as cognitive behavioral therapy for insomnia (CBT-I), sleep monitoring, relaxation techniques, and telehealth consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The digital insomnia therapeutics market consists of sales of virtual cognitive behavioral therapy, audio & video-based sleep aids, light and sound therapy devices, and sleep monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.